Advanced Solid Tumors: XON7 Antibody Study

We are investigating a new antibody treatment for patients with advanced or metastatic solid tumors. This study aims to evaluate its safety and how well it works in treating these cancers.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Jules Bordet
Medical Oncology
Negenmanneke, Belgium
Institut Bergonie
Medical Oncology
Bordeaux, France
Centre Leon Berard
Medical Oncology
Meyzieu, France

Sponsor: Xenothera
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.